Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer

Triple-negative breast cancer (TNBC) due to lack of clear target and notorious “cold” tumor microenvironment (TME) is one of the most intractable and lethal malignancies. Tuning “cold” TME into “hot” becomes an emerging therapeutic strategy to TNBC. Herewith, we report that integrin-targeting micell...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Beibei, Qu, Yan, Sun, Yinping, Zhao, Songsong, Yuan, Jiandong, Zhang, Peizhuo, Zhong, Zhiyuan, Meng, Fenghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879764/
https://www.ncbi.nlm.nih.gov/pubmed/36733927
http://dx.doi.org/10.1016/j.bioactmat.2023.01.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879764/
https://www.ncbi.nlm.nih.gov/pubmed/36733927
http://dx.doi.org/10.1016/j.bioactmat.2023.01.014

Ejemplares similares